about
beta-D-glucosyl-N-(docosanoyl)sphingosine1-(beta-D-galactosyl)-N-behenoylsphingosineN-(hexadecanoyl)-beta-D-galactosylsphingosineD-glucosylsphingosinebeta-D-galactosyl-N-(tetracosanoyl)sphingosinebeta-D-glucosyl-N-(hexacosanoyl)sphingosinealpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/16:0)alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0)alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/20:0)alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/22:0)alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0)alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:1(15Z))beta-D-glucosyl-(1<->1')-N-[(15Z)-tetracosenoyl]sphinganinebeta-D-glucosyl-(1<->1')-N-eicosanoylsphinganinebeta-D-galactosyl-(1<->1')-N-eicosanoylsphinganinebeta-D-glucosyl-(1<->1')-N-docosanoylsphinganinebeta-D-galactosyl-(1<->1')-N-docosanoylsphinganinebeta-D-glucosyl-(1<->1')-N-tetracosanoylsphinganinebeta-D-galactosyl-(1<->1')-N-tetracosanoylsphinganinebeta-D-glucosyl-(1<->1')-N-hexacosanoylsphinganinebeta-D-galactosyl-(1<->1')-N-hexacosanoylsphinganinebeta-D-glucosyl-(1<->1')-N-[(17Z)-hexacosenoyl]sphinganinebeta-D-galactosyl-(1<->1')-N-[(17Z)-hexacosenoyl]sphinganinebeta-D-glucosyl-N-hexadecanoylsphingosinebeta-D-glucosyl-N-octadecanoylsphingosinebeta-D-galactosyl-N-octadecanoylsphingosinebeta-D-glucosyl-N-eicosanoylsphingosinebeta-D-galactosyl-N-eicosanoylsphingosinebeta-D-glucosyl-N-(tricosanoyl)sphingosinebeta-D-galactosyl-N-(tricosanoyl)sphingosinebeta-D-glucosyl-N-(tetracosanoyl)sphingosinebeta-D-galactosyl-N-(hexacosanoyl)sphingosinebeta-D-glucosyl-N-[(17Z)-hexacosenoyl]sphingosinebeta-D-galactosyl-N-[(17Z)-hexacosenoyl]sphingosinebeta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-hexadecanoylsphingosinebeta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-octadecanoylsphingosinebeta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-eicosanoylsphingosinebeta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-tetracosanoylsphingosinebeta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(15Z)-tetracosenoyl]sphingosinebeta-D-galactosyl-(1<->1')-N-hexadecanoylsphinganine
P31
Ionization and fragmentation of neutral and acidic glycosphingolipids with a Q-TOF mass spectrometer fitted with a MALDI ion source.Newly discovered neutral glycosphingolipids in aureobasidin A-resistant zygomycetes: Identification of a novel family of Gala-series glycolipids with core Gal alpha 1-6Gal beta 1-6Gal beta sequences.Structural characterization of neutral glycosphingolipids by thin-layer chromatography coupled to matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight MS/MS.Automated normal phase nano high performance liquid chromatography/matrix assisted laser desorption/ionization mass spectrometry for analysis of neutral and acidic glycosphingolipids.Biochemical studies on sphingolipids of Artemia franciscana: novel neutral glycosphingolipids.Systematic analyses of free ceramide species and ceramide species comprising neutral glycosphingolipids by MALDI-TOF MS with high-energy CID.Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptorsA novel glycosphingolipid-degrading enzyme cleaves the linkage between the oligosaccharide and ceramide of neutral and acidic glycosphingolipids.Biochemical studies on sphingolipids of Artemia franciscana: complex neutral glycosphingolipids.Structural characterization of neutral glycosphingolipids using high-performance liquid chromatography-electrospray ionization mass spectrometry with a repeated high-speed polarity and MSn switching system.Application of direct HPTLC-MALDI for the qualitative and quantitative profiling of neutral and acidic glycosphingolipids: the case of NEU3 overexpressing C2C12 murine myoblasts.Structural Characterization of Neutral Glycosphingolipids from 3T3-L1 Adipocytes.On-Tissue Phospholipase C Digestion for Enhanced MALDI-MS Imaging of Neutral Glycosphingolipids.Isolation and structural analysis of three neutral glycosphingolipids from a mixed population of Caenorhabditis elegans (Nematoda:Rhabditida).Structural analysis of neutral glycosphingolipids from Ascaris suum adults (Nematoda:Ascaridida).Binding of Pseudomonas aeruginosa to neutral glycosphingolipids of rabbit corneal epitheliumHigh-performance thin-layer chromatography/mass spectrometry for the analysis of neutral glycosphingolipids.Dengue virus type 2 recognizes the carbohydrate moiety of neutral glycosphingolipids in mammalian and mosquito cells.Thin-layer chromatography of neutral glycosphingolipids.Neutral glycosphingolipids of serum lipoproteins in Fabry's disease.The glycolipid transfer protein (GLTP) domain of phosphoinositol 4-phosphate adaptor protein-2 (FAPP2): structure drives preference for simple neutral glycosphingolipids.Neutral glycosphingolipids induce cell-cell aggregation of a variety of hematopoietic cell lines.Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives.Isolation and partial characterization of the neutral glycosphingolipids and gangliosides of the human heart.Analysis of derivatized ceramides and neutral glycosphingolipids by high-performance tandem mass spectrometry.Estrogen-induced alterations of the acidic and neutral glycosphingolipids of rat kidney.Generalized accumulation of neutral glycosphingolipids with G M2 ganglioside accumulation in the brain.Characterization of neutral glycosphingolipids in rat lens.Characterization of porcine kidney neutral glycosphingolipids: identification of a carbohydrate antigen recognized by human natural antibodies.Stage-specific expression of fuco-neolacto- (Lewis X) and ganglio-series neutral glycosphingolipids during brain development: characterization of Lewis X and related glycosphingolipids in bovine, human and rat brain.Neutral glycosphingolipids and gangliosides of human lung and lung tumours.Studies on the chemical structure of neutral glycosphingolipids in eggs of the sea hare, Aplysia juliana.
P921
Q27104892-405105F0-5ECE-4830-B030-AD45DD408A5BQ27105056-D49D1A23-354B-4AEA-A627-2D1C46C3BA16Q27105092-0C538705-A73B-41CF-B5A6-E3A5CB5F8B3FQ27106311-9EFD96E5-EA8A-451D-A683-5174F1A43F7AQ27145159-52086315-194F-42A7-973D-96A6171F2E02Q27145229-B4741591-DD0A-4DA2-A167-5AF190670320Q27157991-38BBDEDF-763C-421A-8391-A037B3C0921EQ27157992-7BFC62D7-DC10-4B48-83B0-31422E1EC32DQ27157993-EC8B4E54-C590-4579-975B-657EB5DF8BFFQ27157994-B7273D3E-B22F-46AA-B2FA-502540A38C81Q27157995-D0BB64D3-0BB1-47BE-84E9-3C74F53B2300Q27157996-5FD839BD-D53E-43FD-9B5B-378CC6EB241DQ27157997-E797C45F-A8D1-4430-B718-6F25ACB5DDFAQ27158002-3737B02B-42A6-4360-B7A8-B1D62C1E32A1Q27158003-267C4941-38F4-4C38-879E-DCE1580B96C2Q27158004-4AF7B194-D1BC-4AE8-AA77-810087A70250Q27158005-A96F7583-7A26-4ABB-86B7-3BACD5D449B3Q27158006-7811958C-3A1B-4F94-B71D-2D2ADAD25814Q27158007-008728E3-450A-48DD-A1ED-A2ECF5C5A6F3Q27158009-2DB023E3-5771-452B-875B-B11D976BAA5CQ27158011-317C5E2D-B74F-47AF-BAAF-AAC6930C65C6Q27158012-91CE06F5-BEC3-4BE1-84E9-71BC3F6156D6Q27158013-902FF900-F46D-4B3F-89BF-AFAC6B119945Q27158014-730B7A4F-4B04-47CF-85C6-5E08B284C031Q27158015-807B82EC-9D36-41BD-80F3-B0AF36628B98Q27158016-53FDA4CD-66D3-48CE-9553-7C4E9E9D1F50Q27158017-5EFD8E66-24A5-4366-868B-E9DE048A085CQ27158018-E54D18E6-0A69-4889-B5D9-B10B29D52597Q27158029-A3A2203A-EA42-49DD-95B9-D5F1FE9D565BQ27158030-2DC8F17F-638C-4428-AB7D-1C40E692A1E7Q27158034-51AE793D-D68E-4216-9ECE-AF4B87A25BE0Q27158037-F3AF55CD-0111-43EB-8E45-8CC476E23655Q27158038-4F900880-3F7D-4EAD-A2C7-7914BA985682Q27158039-466B70BB-8C79-4184-B1DB-4F99015E0E09Q27158044-167DB09A-C62A-4C66-BD0E-1C5CA0DEB493Q27158045-514FA2FF-5891-4E61-81DB-DDB9199B7D88Q27158047-74BB67B4-BC1F-43EF-BD14-58BBEFFEF56EQ27158050-32062B3D-D04F-4DF2-BC21-DE655734E4A5Q27158051-217C2142-C011-4631-8587-1E4A97DC1975Q27158065-EA6EF79D-5222-403C-AF98-14417E9437CE
P31
Q31031291-FB98ECF7-6ADD-4001-B39A-6AB604A1EFF6Q31064219-10531FEA-8929-46D7-84F0-3A6DB45E8140Q33253790-B05B631F-87EF-4222-847B-4DCF0A82CD7CQ33323055-EC093BC4-909B-49A2-8404-C81076F61EF0Q33742978-A0089630-EB38-4669-929E-8D61087A9F5FQ33844769-95A2D0B5-41F7-40C1-8B67-0A9B161CD9E3Q33993186-C246000A-CB7B-4DCD-8C4F-BE2B366476BAQ34190160-2D6FDC18-D1B8-4240-8A36-66A1FC3FC8B7Q34379048-209C443B-843D-4DBC-A9FD-BCA36A01C5DDQ34957277-D0057FD1-362C-44B8-8017-485528238F3DQ35077360-62A7447C-B065-4649-AD7E-F16C3C7D2FDAQ35971323-760CDF2B-36C9-4CD7-A780-C9298ACFC179Q36026034-7DF0E074-38C4-4CEB-85FE-85B77BE760B3Q36858155-3A63A16C-DF43-4619-9E99-5B2FB8E58AB6Q36860177-3BBA1B3B-2606-47CD-A2E1-909A48AA0785Q36975576-BA2D0795-03B8-45A7-986B-4E4C2464B342Q37899336-E9DC3CD2-8407-4D11-85DC-3718406A1B64Q39591206-AA95D4B8-1B15-44D2-B413-04088FDDA5ABQ39925329-A313B7BA-6E06-4114-86B4-34241156F3C3Q40000691-08986A22-554F-442A-B7D6-2AD809A768A3Q40723463-A0AABFD0-7176-43BC-9385-75C9D3D035B7Q41101571-8A640E40-C247-446D-8100-61BD829E4E76Q41262205-53FA367E-705B-4440-84C2-A76DAC18D8EAQ41459561-F15671DF-60E6-4D9A-B784-75D5E324332CQ41957137-D861319D-CCCA-4DE4-AB6B-5CABEEC5E154Q42138504-57D901CF-DF82-4E6C-86EF-4F31D1F1A274Q42237048-6CF6C924-1D1E-48A9-8616-53BAEA2347C7Q42279654-2D87F7A0-5F2B-4898-8A9D-978AF2B46AC2Q42280573-91673829-A5BC-400D-B20D-6505B09E9F46Q42554396-7D08A0CA-9A2A-481B-8C8F-A269C3F2F805Q42936629-549B6BEE-0B2E-431C-8114-FCA6696250DEQ43421084-7D43FB16-2B50-46A6-BD68-C7AC146D2BF9
P921
description
class of chemical compounds, a ...... nsubstituted glycosyl moieties
@en
name
neutral glycosphingolipid
@en
type
label
neutral glycosphingolipid
@en
altLabel
neutral glycosphingolipids
@en
prefLabel
neutral glycosphingolipid
@en